Delivery Order SPE2DR25D2003-SPE2DR26FR01J
- Not listed
- The Defense Logistics Agency awarded a $5,700.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on November 13, 2025, with completion scheduled for November 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes, with a ceiling value of $6,696.44. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete openly in federal pharmaceutical procurement. The contract is set to be completed by November 4, 2025, and will be performed at the contractor's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,679.00 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 5, 2025, with completion expected by December 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,335.80 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes with a ceiling value of $1,034.85. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $5,174.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive, non-set-aside award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,449.50 on June 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of July 15, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger procurement relationship with the federal government. This delivery order is a child contract issued under...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR01JDelivery Order
The Defense Logistics Agency awarded a $6,679.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), represents a competitively awarded, non-set-aside procurement with an ultimate completion date of December 8, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's critical role as a pharmaceutical supplier to federal military and healthcare systems. As a major distributor and healthcare solutions provider, the company leverages its prime indefinite delivery vehicle with DLA to supply a comprehensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs globally. The firm fixed-price structure and rapid completion timeline reflect the essential nature of vaccine procurement for defense medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 12/4/25 |